Tai, GJ;
Yu, QQ;
Li, JP;
Wei, W;
Ji, XM;
Zheng, RF;
Li, XX;
... Xu, M; + view all
(2022)
NLRP3 inflammasome links vascular senescence to diabetic vascular lesions.
Pharmacological Research
, 178
, Article 106143. 10.1016/j.phrs.2022.106143.
Preview |
Text
Wei_Revised manuscript_Final.pdf Download (440kB) | Preview |
Preview |
Text
Figures 1-6.pdf - Accepted Version Download (1MB) | Preview |
Abstract
Vascular senescence is inextricably linked to the onset and progression of cardiovascular diseases (CVDs), which are the main cause of mortality in people with Type 2 diabetes (T2DM). Previous studies have emphasized the importance of chronic aseptic inflammation in diabetic vasculopathy. Here, we found the abnormal activation of NLRP3 inflammasome in the aorta of both old and T2DM mice by immunofluorescence and Western Blot analysis. Histopathological and isometry tension analysis showed that the presence of T2DM triggered or aggravated the increase of vascular aging markers, as well as age-associated vascular impairment and vasomotor dysfunction, which were improved by NLRP3 deletion or inhibition. Differential expression of aortic genes links to senescence activation and vascular remodeling supports the favorable benefits of NLRP3-/- during T2DM. In vitro results based on primary mice aortic endothelial cells (MAECs) and vascular smooth muscle cells (VSMCs) demonstrate that NLRP3 deficiency attenuated premature senescence and restored proliferation and migration capability under-stimulation, and partially ameliorated replicative senescence. These results provide an insight into the critical role of NLRP3 signaling in T2DM-induced vascular aging and loss of vascular homeostasis, and provide the possibility that targeting NLRP3 inflammasome might be a promising strategy to prevent diabetic vascular senescence and associated vascular lesions.
Archive Staff Only
 |
View Item |
